Business context and reporting period
CorVel Corporation provides workers’ compensation and auto-claims medical cost containment and managed-care services, including patient management and network solutions. This 10-Q covers the quarter and six months ended September 30, 2015, the second quarter of fiscal 2016, with comparisons to the same periods in 2014. The request metadata says “2014 Q2,” but the filing itself reports 2015 results.
Financial results and liquidity
| Metric | Three months ended September 30, 2015 | Change year over year | Six months ended September 30, 2015 | Change year over year |
|---|---|---|---|---|
| Revenue | $124.5 million | +0.6% | $251.4 million | +1.3% |
| Gross profit / margin | $26.7 million / 21.4% | +4.8%; margin +0.8 percentage points | $52.9 million / 21.0% | -0.6%; margin -0.4 percentage points |
| Income before taxes | $13.5 million | +6.0% | $24.7 million | -5.8% |
| Net income | $8.3 million | +4.9% | $15.2 million | -6.3% |
| Diluted EPS | $0.41 | +$0.04 | $0.75 | -$0.02 |
| Operating cash flow | Not separately reported for the quarter | $24.6 million | Up from $15.6 million |
Quarterly performance improved as lower cost of revenues more than offset higher general and administrative expense. For the six-month period, costs grew faster than revenue and net income declined. The six-month effective tax rate was 38.6%, compared with 38.3% in 2014.
Cash and cash equivalents were $24.9 million at September 30, 2015, down $0.6 million from March 31. Working capital was $45.5 million. Six-month investing cash outflow was $8.6 million, including $8.0 million of property and equipment purchases; financing cash outflow was $16.6 million, primarily from $18.8 million of share repurchases. The company reported no debt outstanding. Its renewed revolving credit facility provides up to $10 million and expires in September 2016; $4.5 million of letters of credit were outstanding separately and do not reduce facility availability.
Material changes versus prior comparable periods
- For the quarter, patient management revenue rose 1.5% to $68.1 million, while network solutions revenue declined to $56.3 million. Gross margin improved from 20.6% to 21.4%.
- For the six months, patient management revenue increased 5.1% to $139.3 million, attributed to higher service levels for new and existing TPA customers. Network solutions revenue fell 3.1% to $112.1 million, primarily due to a 3% decline in bill-review volume following the loss of several customers.
- Six-month cost of revenues rose 1.9%, including higher direct salaries associated with increased headcount and annual raises. General and administrative expense increased 4.5%; management attributed the rise primarily to one-time refunds recognized in the prior year.
- Share repurchases reduced weighted average diluted shares 4.7% in the quarter and 4.4% over six months. This supported quarterly diluted EPS growth despite modest revenue growth. The company repurchased 559,702 shares for $18.8 million during the six months.
Outlook, risks, contingencies and unusual items
Management provided no specific earnings or revenue guidance. It said cash, expected internally generated funds and the credit facility should meet expected cash requirements for at least the next 12 months, including operations, capital spending and the ongoing repurchase program. Management noted that results are not necessarily indicative of full-year results. The company also cautioned that the third fiscal quarter typically has fewer working days due to vacations, weather and holidays.
Key risks cited include declining workers’ compensation claims or injured-worker counts, customer losses and contract termination, competition and customers bringing services in-house, pressure on network solutions demand, labor availability and costs, regulatory changes, litigation and professional liability, cybersecurity or system interruptions, and dependence on key personnel. Management said ordinary-course litigation was not expected to result in a material payment. Operating lease commitments totaled $45.6 million; uncertain tax positions were $1.9 million, all classified as due within one year in the filing’s table.
After quarter-end through October 30, the company repurchased 99,403 shares for $3.3 million at an average $33.07 per share. The company reported no indicators of impairment of goodwill or other long-lived assets at September 30. It is evaluating the new revenue recognition standard, effective for its fiscal year beginning April 1, 2018, and had not estimated its financial impact.
Most important facts for investors to verify
- Confirm the filing period: the document is for the quarter ended September 30, 2015, not 2014 Q2.
- Track whether the six-month decline in earnings and network solutions revenue persists, and whether patient management growth continues to offset it.
- Review cash conversion and working-capital movements, particularly the $7.4 million increase in customer deposits that reduced operating cash flow, alongside the increase in accrued liabilities.
- Assess the pace and price of share repurchases, remaining authorization, and their effect on cash available for investment or acquisitions.
- Monitor customer retention, bill-review volumes, labor costs, legal and regulatory developments, and compliance with credit-facility covenants.